GL1X · GenesisL1 explorer

Research workbench

Structure of the engineered retro-aldolase RA95.5-8F with a bound 1,3- diketone inhibitor

Analyse Structure of the engineered retro-aldolase RA95.5-8F with a bound 1,3- diketone… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5AN7
Type
protein
Length
243 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RA95.5-8F
Ligands
LLK, PO4
Pockets
1 · best druggability 0.56

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARA95.5-8Fprotein24341% helix, 16% strand—

Ligands and binding sites

  • LLK · (2E)-1-(6-methoxynaphthalen-2-yl)but-2-en-1-one · ligand · chains A
  • PO4 · Phosphate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11870.560.7930LLK

Modifications

Observed in the structure: 1 covalent, 1 modified (covalent ligand, oxidation).

Compared structures

  • 5AN7 · Structure of the engineered retro-aldolase RA95.5-8F with a bound 1,3-diketone inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.